Cadrenal Therapeutics (CVKD) Prepaid Assets (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Prepaid Assets of $428071.0 for Q1 2026, up 113.89% sequentially from $200140.0 in Q4 2025, and down 25.63% YoY from $575605.0 in Q1 2025.
Cadrenal Therapeutics (CVKD) Prepaid Assets (2022 - 2026) Analysis & Trends
Cadrenal Therapeutics has reported Prepaid Assets for 5 years, with the latest figure at $428071.0 in Q1 2026.
- Quarterly Prepaid Assets fell 25.63% year-over-year to $428071.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $428071.0 (down 25.63% YoY) and the FY2025 annual result came in at $200140.0, up 373.63% from the prior year.
- Prepaid Assets grew to $428071.0 in Q1 2026 per CVKD's latest filing, from $200140.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $575605.0 in Q1 2025 and troughed at $22715.0 in Q4 2022.
- A 5-year average of $241774.1 and a median of $217543.0 in 2024 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 373.63% in 2025, down 39.48% in 2025.
- Over 5 years, Prepaid Assets stood at $22715.0 in 2022, then surged by 130.79% to $52425.0 in 2023, then declined by 19.4% to $42257.0 in 2024, then soared by 373.63% to $200140.0 in 2025, then jumped by 113.89% to $428071.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $428071.0, $200140.0, and $116015.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cadrenal Therapeutics | 4.59 Mn | 2.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 410,105.00 |
| Mar 31, 2026 | 428,071.00 |
| Dec 31, 2025 | 200,140.00 |
| Sep 30, 2025 | 116,015.00 |
| Jun 30, 2025 | 358,357.00 |
| Mar 31, 2025 | 575,605.00 |
| Dec 31, 2024 | 42,257.00 |
| Sep 30, 2024 | 191,706.00 |
| Jun 30, 2024 | 234,946.00 |
| Mar 31, 2024 | 293,767.00 |
| Dec 31, 2023 | 52,425.00 |
| Sep 30, 2023 | 168,602.00 |
| Jun 30, 2023 | 289,328.00 |
| Mar 31, 2023 | 410,903.00 |
| Dec 31, 2022 | 22,715.00 |